VAN SCOYOC ASSOCIATES for MACANDREWS & FORBES GROUP LLC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Monitor global trade related issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT HENKEN | — |
| JENNIFER LATOURETTE | — |
Taxation/Internal Revenue Code TAX
No lobbying activity
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT HENKEN | — |
Postal POS
Monitor Postal reform issues, generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT HENKEN | — |
| JENNIFER LATOURETTE | — |
Health Issues HCR
H.R.2996, More Efficient Tools to Realize Information for Consumers (METRIC) Act, Prescription Drug Monitor the following: Pandemic and All-Hazards Preparedness Reauthorization, Medical Countermeasures Prescription drug reform related issues S.1895, Lower Health Care Costs Act, generally Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, June 24, 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT HENKEN | — |
Telecommunications TEC
H.R.2013, Information Transparency & Personal Data Control Act, Data privacy issues, generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT HENKEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.